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Abstract
Background: Constipation severity is often defined by symptoms including feelings of complete evacuation,
straining, stool frequency and consistency. These descriptors are mostly obtained in the absence of laxative use.
For many constipated patients laxative usage is ubiquitous and long standing. Our aim was to determine the
impact of laxative use upon the stereotypic constipation descriptors.
Methods: Patients with confirmed slow transit constipation completed 3-week stool diaries, detailing stool
frequency and form, straining, laxative use and pain and bloating scores. Each diary day was classified as being
under laxative affect (laxative affected days) or not (laxative unaffected days). Unconditional logistic regression was
used to assess the affects of laxatives on constipation symptoms.
Results: Ninety four patients with scintigraphically confirmed slow transit constipation were enrolled in the study.
These patients reported a stool frequency of 5.6 ± 4.3 bowel motions/week, only 21 patients reported <3 bowel
motions/week. Similarly, 21 patients reported a predominant hard stool at defecation. The majority (90%) of
patients reported regular straining. A regular feeling of complete evacuation was reported in just 7 patients. Daily
pain and/or bloating were reported by 92% of patients. When compared with laxative unaffected days, on the
laxative affected days patients had a higher stool frequency (OR 2.23; P <0.001) and were more likely to report
loose stools (OR 1.64; P <0.009). Laxatives did not increase the number of bowel actions associated with a feeling
of complete evacuation. Laxative use had no affect upon straining, pain or bloating scores
Conclusions: The reporting of frequent and loose stools with abdominal pain and/or bloating is common in
patients with slow transit constipation. While laxative use is a significant contributor to altering stool frequency and
form, laxatives have no apparent affect on pain or bloating or upon a patients feeling of complete evacuation.
These factors need to be taken into account when using constipation symptoms to define this population.
Background
Severe constipation is a chronic condition with major
morbidity and health care burden [1,2]. As symptoms of
constipation are the first points of discussion between a
patient and their clinician the ability to subtype patients
based upon these symptoms is important because, ide-
ally it should direct a logical and cost-effective investiga-
tive pathway without then e e df o re x p e n s i v ea n d
inconvenient testing.
Two of the most commonly identified symptoms of
constipation are infrequent and hard lumpy stools. Both
of these characteristics are fundamental to major
current consensus-derived definitions of constipation
such as the Rome III criteria [3] and the American Col-
lege of Gastroenterology Chronic Constipation Task
Force [4]. The Rome III criteria also include straining, a
feeling of incomplete evacuation and manual maneuvers
to facilitate defecation. It is noteworthy that all these
criteria are established in the absence of laxative use.
Indeed the Rome criteria qualified by the statement that
loose stools are rarely present without the use of laxa-
tives [3].
However, the ability to critically and realistically assess
constipation symptoms in the absence of laxative use
can be difficult in a chronically constipated population.
Laxatives remain a primary treatment option in such
patients [5,6] and in many instances patients may have
been taking laxatives for many years. Therefore when
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any medium, provided the original work is properly cited.asked at interview or in a questionnaire to detail their
stooling characteristics in the absence of laxatives they
have to do so from memory. Responses based purely on
recall of stooling habits have been shown to be unreli-
able [7-9].
The use of stool diaries avoids the problems associated
with patients’ recall ability [9-16]. However, in systema-
tic studies of constipation these diaries are usually kept
with patients off laxatives [8,13]. As laxative usage can
potentially alter stool frequency and consistency, the
stereotypic classifier of infrequent hard stools in severe
constipation may bear little or no resemblance to the
reality of the day-to-day life in these patients.
This question is important to the clinician and the
researcher, particularly when trying to quantify stooling
habits and outcomes in clinical trials. There is a need to
try and classify constipated patients according to sub-
type [17,18]. This is best achieved by physiological func-
tion tests of colonic transit and anorectal evacuation.
These tests are costly, inconvenient and not always
readily available. Currently, based on existing symptom
measurement tools, prediction of the physiological mea-
s u r e si si m p e r f e c t[ 5 ] .I ti sunknown whether laxative-
related perturbation of symptoms may contribute to this
lack of predictive value of symptoms for measureable
mechanical dysfunction.
There has never been a systematic evaluation of the
potential impact of laxative usage on symptoms in
patients with constipation. Utilising a 3-week stool diary
completed by patients with slow transit constipation,
our aim was to evaluate, on a day-to-day basis, this rela-
tionship and determine the specific impact of laxative
use, if any, upon stool frequency and form, straining,
feelings of complete evacuation in addition to reported
instances of abdominal pain and bloating. Specifically
we hypothesised that all of these symptoms are affected
by laxative use in patients with slow transit constipation.
Methods
Population sample
Patients included in this study were referred to tertiary
centres for potential inclusion in a trial of the treatment
of constipation with sacral nerve stimulation. For the
initial inclusion in the trial patients had to meet the fol-
lowing inclusion criteria; i) aged 18 - 75 yrs; ii) deemed
have Rome III criteria for constipation [3] (assessed by
DZL and IJC); iii) a failed response to standard therapies
including laxatives, dietary modification and exercise;
a n di v )C o n f i r m e ds l o wt r a n s i tc o n s t i p a t i o n[ 1 9 ] .
Patients were excluded from the study if they had any
of the following; i) metabolic, neurogenic or endocrine
disorder(s) known to cause constipation (e.g. hypercal-
caemia, hypothyroidism, diabetes, multiple sclerosis, Par-
kinson’s, scleroderma); ii) consumed drugs which list
constipation as a potential side effect deemed to be
clinically relevant by the referring physician (e.g. calcium
channel blockers); iii) prior abdominal radiotherapy; iv)
prior abdominal surgery (except cholecystectomy,
appendicectomy, inguinal hernia repair); v) current preg-
nancy; vi) current or prior history of malignancy.
All participants meeting these criteria gave written,
informed consent and the studies were approved of in
Australia by the Human Ethics Committees of the
South Eastern Area Health Service, Sydney and the Uni-
versity of New South Wales (05/122)
Stool diary
Once patients met the inclusion criteria they were given
stool diaries to complete. The stool diary is based on an
instrument used for many years in our laboratory. For
the present study questions of specific interest have
been added concerning “feeling of incomplete evacua-
tion” as well as the laxative use, type and dose. Each
stool diary consisted of 3 pages, 1 for each week of the
study. On each day patients were requested to enter; i)
their stool frequency (0,1,2,≥3); ii) the stool form of
each bowel action (based upon the Bristol stool scale
[20], ranging from 1 = separate hard lumps, like nuts; 4
= like a sausage or snake smooth and soft; 7 = watery,
no solid pieces); iii) straining (yes/no); iv) a sense of
complete evacuation (yes/no); v) pain and bloating
scores (0 = none, 1 = present but tolerable, 2 = present
and interfering with but not preventing normal daily
activities like work and sleep, 3 = preventing normal
daily activities); vi) laxative use (yes/no) and if yes what
type and dose. In a cover sheet patients were also asked
how long they had had constipation. Completed diaries
were placed into a self addressed prepaid envelope and
returned by post to the investigators.
Colonic transit studies
Colonic transit was measured using a standard nuclear
medicine technique previously validated at St. George
Hospital [21,22]. All laxatives were stopped 3 days
before the scan and during scanning period. The proto-
col and analysis of the colonic scintigraphy have been
described previously [17,23]. The scintigraphic definition
of delayed transit constipation was met if the study
showed isotope retention of greater than 9% in the right
(caecum to mid transverse) or left colon (mid-transverse
to distal descending colon) at 72 hrs [21,22].
Data analysis & statistics
Since the effect of laxative use is likely to be relatively
short-lived we decided against averaging data over the
three-week period. Instead we looked at the data at a
daily level with each day classified as a day on which
laxatives were in affect or not. The term “laxative-affect
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taken as well as the following day since a laxative taken
late on one day was likely to have some carry over effect
into the following day. We have used the term “laxative
unaffected days” to define all other days. The affect of
laxative use on bowel habit was then assessed via
unconditional logistic regression with standard errors
adjusted using the linearization method [24] to account
for within-subject correlation which involves adjusting
the naive standard errors by a variance inflation factor.
Odds ratios from the model are used to interpret the
direction and effect size of laxatives on bowel habit and
are reported with 95% confidence intervals and p-values.
An odds ratio >1 indicates that laxative effect is asso-
ciated with higher levels of a bowel habit variable while
odds ratios <1 indicate an association with lower levels
of that variable. An odds ratio of exactly 1.0, or very
close to it, indicates no effect of laxatives on that bowel
habit variable.
Stool Form
As reported previously [13] the Bristol stool form scale
was reduced to a three-point scale by combining scores
o f1a n d2i n t oa“hard” group (Type 1), scores 3 and 4
as a “normal” group (Type 2) and scores of 5-7 as a
“soft” group (Type 3).
Laxative Use
The patients in this study used a wide variety and com-
bination of laxatives. We defined a laxative as an agent
specifically designed to stimulate the evacuation of
faeces. The vast majority of laxatives used fell into two
specific groups; i) Stimulant laxatives (Senna, Bisacodyl,
Coloxyl, Durolax, Aloe); ii) Osmotics Laxatives (PEG,
Milk of Magnesia, Magnesium sulfate). Twenty of the
patients also used enemas. In 18 patients enemas were
used on ≤5 occasions during the 3-week period and
always in combination with other laxatives. In 2 patients
enemas were used without any other laxatives. These
two patients used the enemas on every 2nd or 3rd day
respectively. The laxatives were also occasionally supple-
mented with bulking agents such as prunes or bran.
The wide variety of laxative doses and combinations
prevented any meaningful statistical comparison
between specific laxative type/dose and symptoms.
Results
A total of 94 patients (5 male; mean age 43 ± 17 yrs)
with scintigraphically confirmed slow transit were
enrolled in the study. As these were patients being
selected for possible inclusion in a trial for treatment of
constipation with sacral nerve stimulation the response
rate was excellent, with all patients completing the dia-
ries. The average colonic retention at 72 h was 73.9%. ±
25% (Figure 1). The majority of patients (n = 85; 91%)
reported having suffered from constipation for longer
than 5 years (62% for longer than 10 yrs). The remain-
ing 9 patients reported constipation for at least 2 years.
Stool Diary
Laxative use was prominent in the majority of patients
with 28 (30%) using laxatives on a daily basis, 49 (52%)
using laxatives intermittently and 17 (18%) reporting no
laxative use. The stool frequency collated from the stool
dairies was 5.6 ± 4.3 bowel motions per week. Only 21
(22%) patients reported a stool frequency of <3 bowel
motions/week with 35 (37%) reporting at least one
bowel motion per day (Figure 2). A predominant hard
stool at defecation was reported by 21 (22%) patients,
while 28 (30%) reported loose stool. Straining during a
bowel action was common with 30 (32%) having to
strain for every bowel action and only 10 (11%) report-
ing that they never strain. Despite the frequency of the
Figure 1 The percent retention of isotope in the colon at 72
hr.
Figure 2 Weekly stool frequency reported by the patients with
slow transit constipation.
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rarely) reported a feeling of complete evacuation. Indeed
a regular feeling of complete evacuation was reported in
just 7 (8%) patients. Daily pain or bloating scored as
interfering or preventing normal daily activities was
reported by 27 (28.7%) and 40 (42.5%) patients, respec-
tively. Less than 8% of patients reported no pain or
bloating.
Laxative affected and unaffected days
These patients yielded 1051 diary days; 497 laxative-affect
days and 554 laxative unaffected days. The statistical
comparisons between stooling characteristics on laxative
affected and unaffected days are shown in table 1 and
Figure 3. A stool frequency of ≥1 bowel motion per day
occurred on 70% of the laxative affected days and 41% of
t h el a x a t i v eu n a f f e c t e dd a y s( P < 0.0001). Similarly on
54% of laxative affected days patients reported loose stool
compared to the 28% of laxative unaffected days (P <
0.0001). A feeling of complete evacuation was slightly
increased on laxative affected days, however this differ-
ence was not significant (table 1). Laxative use had no
effect upon straining, pain or bloating scores (table 1).
Discussion
This study indicates that frequent, loose stools, pain and
bloating are all commonly reported in a patient group
with confirmed slow colonic transit and constipation.
Indeed three quarters of our patients fell within the
defined 3/wk - 3/day normal range for stool frequency
[25,26] and 78% described normal to loose stool. Strain-
ing at stool and a feeling of incomplete evacuation were
also commonly reported. Over 80% of our patients regu-
larly took laxatives, and our data indicate that laxative
Table 1 These odds ratios suggest that among patients
with demonstrated delayed colonic transit days on which
laxatives were either taken or likely to have been in
effect are differentiated from laxative unaffected days
with respect to stool form (higher scores on laxative
days), stool frequency (higher frequency on laxative
days) and feeling of complete evacuation (FOCE: more
likely on laxative effect days) but are not differentiated
with respect to straining, abdominal pain or bloating.
Characteristics Odds ratio 95% CI P - value
Stool form 1.64 1.13, 2.40 0.009
Stool frequency 2.23 1.57, 3.17 <0.001
FOCE 2.01 0.95, 4.22 0.06
Straining 1.10 0.50, 2.45 0.8
Abdominal pain 1.00 0.77, 1.30 >0.9
Abdominal bloating 1.04 0.78, 1.38 0.8
Figure 3 The percentage of days on which; A) at least one
bowel action was passed; B) a loose stool was passed; and C)
a feeling of complete evacuation was achieved, during the
laxative affected and unaffected days. Stool frequency and
incidence of loose stool were significantly increase on laxative
affected days.
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quency and form. However despite increasing the stool
frequency laxatives had little affect on a patient’s ability
to feel as though they had completely evacuated and
they did not reduce the incidence of straining. Laxatives
also had no apparent affect upon abdominal pain and
bloating suggesting that pain and bloating are intrinsic
to the constipation.
Laxatives remain the primary treatment option for
severe constipation [6] and in the US the annual expen-
diture on laxatives is estimated to exceed $US850 M
[27,28]. Yet despite the common usage their potential
impact upon the day-to-day constipation symptoms is
often overlooked and this raises potential problems
when attempting to critically assess the reality of symp-
toms in chronically constipation patients. In this study
91% of our patients reported having constipation for at
least 5 years (62% >10 yrs) and laxative use for many
had become part of every day life. Asking such patients
to detail their stooling habits in the absence of laxative
u s ei su n l i k e l yt op r o v i d er e a l i s t i cd a t a .I n d e e di no u r
experience the classic response to the question “how
often would you open your bowels a week without laxa-
tive use?” is “I’d never go”. While such responses may
represent the patient’s perspective of their bowel func-
tion, several studies have shown that a patients recall
ability of stool habits is inaccurate [7-9].
These inaccuracies could potentially confound study
findings. For example previous studies have suggested
that infrequent stools may indicate delayed transit
[10,12,29] and some studies have presented supportive
evidence for this [30,31], while others have not [9,13].
When looking at the methodology of these studies it is
of interest to note that those that associated infrequent
stools with delayed transit, based the patient’s stool fre-
quency upon answers provided in a questionnaire
[30,31]. Thus the acquired data relied on the patients
recall ability, presumably in the absence of laxatives,
w h i c hi sm o r el i k e l yt oi n d i c a t eal o ww e e k l ys t o o lf r e -
quency. Those studies that found no correlation
between stool frequency and delayed colonic transit
assessed the stool frequency on data obtained in stool
diaries [9,13]. While not directly assessed here our data
would also suggest that neither stool form nor frequency
provides an accurate indicator of slow colonic transit.
To overcome the impact of laxatives upon constipa-
tion symptoms, stool diaries could be maintained in the
absence of laxatives use, however in our experience
chronically constipated patients become dependent on
laxatives and can be unwilling to stop using them for
even short periods of time. Such patients can be
excluded from studies assessing constipation symptoms
[8] but then these studies risk removing patients at the
more severe end of constipation scale.
The potential for laxatives to alter stool frequency and
form can also have implications for studies that use con-
stipation symptoms in an attempt to define constipation
subtypes. The mathematical techniques of factor analysis
have been used in an attempt to determine whether cer-
tain symptoms groups can help to define subtypes of
constipation. Studies applying these techniques have
found conflicting results with Mertz et al [32] identify-
ing 3 constipation subtypes while Eltringham el at [33]
did not. In our own recent study, 4 subtypes were iden-
tified, however there was significant overlap amongst
these subtypes [17]. Given that the approach to consti-
pation subtyping in our study relied entirely on answers
provided in a questionnaire, it is important that patients
understand how they are supposed to complete the
questionnaire. For examplew eh a v eh a dm a n yp a t i e n t s
ask if they should complete the questionnaire based on
what they are like on or off laxatives. Therefore within
any population of constipated patients the question-
naires may be assessing; i) a patient’se s t i m a t eo fw h a t
they believe they would be like without laxatives; ii)
what they are actually like on laxatives; or iii) a combi-
nation of both situations.
While laxatives in this study increased stool frequency,
it is important to note that on the majority of laxative
affected days patients still had to strain to open their
bowels and were left with a feeling of incomplete eva-
cuation. As a consequence the patient still feels consti-
pated. This highlights a potential problem associated
with using stool frequency as a measure of constipation
severity. To manoeuvrer around this many studies use
‘spontaneous bowel motion’ or ‘complete spontaneous
bowel motion’ to define bowel habit [4,34]. However,
once again in chronically constipated patients that have
become dependant upon laxatives, the reality of obtain-
ing several weeks of stool frequency data in the absence
of any laxative use could be difficult. In such patients
we would suggest that a more accurate measure of con-
stipation severity could be the number of days per week
in which a patient achieves a feeling of complete evacua-
tion in light of their laxative use. In our patients, while
many fit the ‘normal’ stool frequency criteria, the vast
majority experienced a bowel movement associated with
a feeling of complete evacuation on less than 3 days per
week.
An important and often overlooked factor to emerge
from our stool diaries is the prevalence of pain and
bloating. Frequent, loose stools, abdominal pain and
bloating are all symptoms commonly associated with
irritable bowel syndrome, and the current Rome criteria
for the diagnosis of constipation does not even mention
t h ep r e s e n c eo fp a i no rb l o a t i n g[ 3 ] .O n l y8 %o fo u r
patients reported an absence of these symptoms whereas
>27% reported these symptoms as interfering or
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shown a large proportion of patients with constipation,
including those with slow transit constipation, poten-
tially met the Rome criteria for IBS [17,35,36], thus
highlighting the need to include pain and bloating in
the assessment of constipation symptoms.
There are potential criticisms with our study. Straining
and pain/bloating, reported by 89% and 92% of our
patients, respectively are commonly reported by patients
who have a disorder of rectal evacuation [37,38]. Given
that tests of anorectal function were not used to exclude
patients with co-existent disordered rectal evacuation, it
is likely that such mixed disorders existed in some of
our study population and this could potentially impact
upon our results. Indeed the inclusion of such patients
has recently been put forward as a potential confounder
in clinical trials of prokinetics in constipation [39].
However, this assertion still remains to be proven and
a st h e r ei sal a r g eb o d yo fe v i d e n c et h a ts u g g e s t st h e r e
are no symptoms that are reliably predictive of an eva-
cuation disorder [35,40-43], we feel that the potential
inclusion of such patients should not detract from the
overall symptomatic findings in our study.
Other potential criticisms of this study include the fact
we did not measure the size or the weight of stools that
were passed and we therefore we have no ability to
determine what a patient considers to be a ‘bowel
motion’. Passing a small amount of hard or liquid stool
may have constituted a bowel motion for some patients.
Of course this factor remains true for almost all symp-
tom based constipation studies. Finally while there is a
risk of non-compliance with reporting the daily symp-
toms, especially over a three week period, we found that
with these particular patients, who were all seeking help
for the constipation symptoms, there was a willingness
to comply and we are therefore confident that these
data are an accurate representation of the symptoms in
this population.
Conclusion
In conclusion these data demonstrate that in the normal
day-to-day life of patients with slow transit constipation
laxative use significantly increases stool frequency and
the incidence of loose stool without reducing the
patients need to strain or increasing their ability to feel
as though they have evacuated completely. Furthermore,
these patients commonly report abdominal pain and
bloating, factors that were not affected by laxative use,
and are therefore a symptomatic component of severe
constipation. We feel that based upon these data; i)
stool frequency and form are poor indicators of consti-
pation severity; ii) abdominal pain and bloating should
be assessed as part of the constipation symptoms; and
iii) daily stool diaries detailing constipation symptoms
should include laxative use. The data derived from such
dairies provides a more realistic insight into the day-to-
day symptoms of patients with constipation.
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